基于氨酸的纳米载体用于抗癌药物输送
Chao-Ping Fu1,2,3, Xing-Yu Cai1,2, Si-Lin Chen1,2
1Institute of Biomaterials and Tissue Engineering & Fujian Provincial Key Laboratory of Biochemical Technology, Huaqiao University, Xiamen 361021, China.
Polymers
|May 27, 2023
概括
氨酸 (HA) 纳米载体为向抗癌药物输送提供了一个生物相容的平台. 这些系统利用HAHA作为杆.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 在瘤学瘤学.
背景情况:
- 氨酸 (HA) 是一个关键的细胞外基因组件,具有出色的生物相容性和准潜力.
- 在许多癌细胞中,HA受体CD44被过度表达,从而使瘤特异性药物输送成为可能.
- 基于HA的纳米载体通过向癌细胞组织,提高药物的有效性和降低毒性.
研究的目的:
- 综合审查基于HA的纳米载体用于抗癌药物输送.
- 讨论制造方法,包括前药物,有机和无机纳米载体.
- 分析这些纳米载体在癌症治疗中的进展,优化和治疗效果.
主要方法:
- 关于用于癌症治疗的基于HA的纳米载体制造的文献综述.
- 纳米载体的分类为原药,有机 (,脂质体,纳米颗粒,微泡,水凝) 和无机复合材料 (金纳米颗粒,量子点,碳纳米管,二氧化).
- 讨论纳米载体设计,优化策略及其对治疗结果的影响.
主要成果:
- 基于HA的纳米载体证明了药物递送效率的提高和瘤向.
- 不同的制造方法产生了各种各样的纳米载体系统,具有量身定制的特性.
- 这些纳米载体在减少目标外积累和残留毒性方面表现有前途.
结论:
- 基于HA的纳米载体代表了先进癌症治疗的有希望的战略.
- 进一步开发和优化对于临床翻译至关重要.
- 综述强调了未来的前景和在现场学到的经验教训.
相关概念视频
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...